
Towards Wnt inhibition without prohibitive toxicity
Towards Wnt inhibition without prohibitive toxicity
Wnt fuels cancer growth and drug resistance in millions of patients each year - yet any attempts to drug it have been blocked by toxicity.
Wnt fuels cancer growth and drug resistance in millions of patients each year - yet any attempts to drug it have been blocked by toxicity.



The Problem
Broad Wnt inhibition is overly toxic
Blocking Wnt signaling broadly leads to dose-limiting toxicity especially in gut and bone
Implicated across all major solid tumors
The Problem
Wnt drives cancer drug resistance
Blocking Wnt signaling broadly leads to dose-limiting toxicity especially in gut and bone
Implicated across all major solid tumors


The Limitation
Dose-limiting bottleneck
Narrow therapeutic window especially limiting in drug combinations
No approved Wnt inhibitor drug
The Limitation
Dose-limiting bottleneck
Narrow therapeutic window especially limiting in drug combinations
No approved Wnt inhibitor drug
The Innovation
Receptor Selective Inhibition
Targeting the specific Wnt receptor a tumor relies on for survival and resistance
Healthy tissue can rely on other receptors
The Innovation
Receptor Selective Inhibition
Targeting the specific Wnt receptor a tumor relies on for survival and resistance
Healthy tissue can rely on other receptors


The Opportunity
Engineered For Tolerability
First-in-class Wnt inhibitor molecule with a wide theraupetic window
Mono- and combination therapy potential
The Opportunity
Engineered For Tolerability
First-in-class Wnt inhibitor molecule with a wide theraupetic window
Mono- and combination therapy potential

Explore our preclinical data
Explore our
preclinical data
Book a call to meet a founder, learn more about our data, and discuss what selective Wnt inhibition could mean for oncology.
Book a call to meet a founder, learn more about our data, and discuss what selective Wnt inhibition could mean for oncology.
Phase 2
Phase 2
Phase 1
Phase 1
Pre-Clinical
Pre-Clinical
Research
Research
The Team
The Team
Pioneered by scientists with two decades and 8,000+ citations in Wnt research. Backed by business veterans.
Pioneered by scientists with two decades and 8,000+ citations in Wnt research. Backed by business veterans.





